Latest presentation

First quarter 2020 Results

Loading video...

Biotec Pharmacon Q1 2020 Report Tromsø, Norway, 23 April 2020 – Biotec Pharmacon (OSE: Biotec) reported sales of NOK 34.3 million (14.8) and an EBITDA of NOK 13.8 million (-3.9) for the first quarter of 2020. Improvements are in all areas of the business. Highlights from Q1 2020 New Group strategy kicks…

View more